Bicarbonate-Buffered Capd Solutions: From Clinical Trials to Clinical Practice

Faller B. , Marichal J.F. Loss of ultrafiltration in CAPD: a role for acetate. Perit Dial Bull 1984; 4: 10–13.

Feriani M. Adequacy of acid base correction in continuous ambulatory peritoneal dialysis. Perit Dial Int 1994; 14(Suppl 3): S133–8.

Jorres A. , Gahl G.M. , Frei U. In vitro studies on the effect of dialysis solutions on peritoneal leukocytes. Perit Dial Int 1995; 15(Suppl 7): S41–6.

Veech R.L. The untoward effects of the anions in dialysis fluids. Kidney Int 1988; 34: 587–97.

Feriani M. , Biasioli S. , Borin D. Bicarbonate buffer for CAPD solution. Trans Am Soc Artif Intern Organs 1985; 31: 668–72.

Feriani M. , Kirchgessner J. , La Greca G. , Passlick-Deetjen J. and the Bicarbonate CAPD Cooperative Group. A randomized multicenter long-term clinical study comparing a bicarbonate buffered CAPD solution with the standard lactate buffered CAPD solution. Submitted for publication.

Feriani M. , Carobi C. , La Greca G. , Buoncristiani U. , Passlick-Deetjen J. Clinical experiences with a bicarbonate buffered (39 mmol/L) peritoneal dialysis solution. Perit Dial Int. In press.

Yatzidis H. Anew stable bicarbonate dialysis solution for peritoneal dialysis: preliminary report. Perit Dial Int 1991; 11: 224–7.

Slingeneyer A. , Faller B. , Michel C. , Przbylski C. , Rolland R. , Mion C. Increased ultrafiltration capacity using a new bicarbonate CAPD solution (Abstract). Perit Dial Int 1993; 13(Suppl 1): S57.

Schambye H.T. , Flesner P. , Pedersen R.B. Bicarbonate versus lactate-based CAPD fluids: a biocompatibility study in rabbits. Perit Dial Int 1992; 12: 281–6.

Coles G.A. , Gokal R. , Ogg C. A randomised controlled trial of a bicarbonate and abicarbonate/lactate containing dialysis solution in CAPD. Perit Dial Int. In press.

Marsiglia J.C. , Cingolani H.E. , Gonzales N.C. Relevance of beta receptor blockade to the negative inotropic effect induced by metabolic acidosis. Cardiovasc Res 1973; 7: 336–43.

Lemann J. Jr. , Litzow J.R. , Lennon E.J. The effect of chronic acid loads in normal man: further evidence for the participation of bone mineral in the defence against chronic metabolic acidosis. J Clin Invest 1966; 45: 1608–14.

Lefebvre A. , de Verneoul M.C. , Gueris J. , Goldfarb B. , Graulet A.M. , Morieux C. Optimal correction of acidosis changes progression of dialysis osteodystrophy. Kidney Int 1989; 36: 1112–8.

May R.C. , Kelly R.A. , Mitch W.E. Mechanisms for defects in muscle protein metabolism in rats with chronic uremia: the influence of metabolic acidosis. J Clin Invest 1987; 79: 1099–103.

May R.C. , Kelly R.A. , Mitch W.E. Metabolic acidosis stimulates protein degradation in rat muscle by a glucocorticoid-dependent mechanism. J Clin Invest 1986; 77: 614–21.

Hara Y. , May R.C. , Kelly R.A. , Mitch W.E. Acidosis, not azotemia, stimulates branched-chain amino acid catabolism in uremic rats. Kidney Int 1987; 32: 808–14.

Papadoyannakis N.J. , Stefanides C.J. , McGeown M. The effect of the correction of metabolic acidosis on nitrogen and protein balance of patients with chronic renal failure. Am J Clin Nutr 1984; 40: 623–7.

Garibotto G. , Russo R. , Sofia A. Skeletal muscle protein synthesis and degradation in patients with chronic renal failure. Kidney Int 1994; 45: 1432–9.

Stein A. , Baker F. , Larratt C. Correction of metabolic acidosis and the protein catabolic rate in PD patients. Perit Dial Int 1994; 14: 187–9.

Bergstrom J. , Alvestrand A. , Furst P. Plasma and muscle free amino acids in maintenance hemodialysis patients without protein malnutrition. Kidney Int 1990; 38: 108–14.

Feriani M. Buffers: bicarbonate, lactate, pyruvate. Kidney Int 1996; 50(Suppl 56): S75–80.

Mandelbaum J.M. , Heistand M.L. , Schardin K.E. Six months’ experience with PD-2 solution. Dial Transplant 1983; 12: 259–60.

Nolph K.D. , Prowant B. , Serkes K.D. Multicentric evaluation of a new peritoneal dialysis solution with a high lactate and low magnesium concentration. Perit Dial Bull 1983; 3: 63–5.

Feriani M. , Ronco C. , La Greca G. Acid base balance with different CAPD solutions. Perit Dial Int 1996; 16(Suppl 1): S126–9.

Feriani M. , Passlick-Deetjen J. , La Greca G. Factors affecting bicarbonate transfer with bicarbonate-containing CAPD solution. Perit Dial Int 1995; 15: 336–41.

Topley N. , Kaur D. , Petersen M.M. , Passlick-Deetjen J. , Coles G.A. , Williams J.D. Biocompatibility of bicarbonate buffered peritoneal dialysis fluids: influence on mesothelial cell and neutrophil function. Kidney Int 1996; 49: 1447–56.

Williams B. , Hattersley J. , Layward E. , Walls J. Metabolic acidosis and skeletal adaptation to low protein diets in chronic uraemia. Kidney Int 1991; 40: 779–86.

Papadoyannakis N.J. , Stefanidis C.J. , Patricarea A. , Kotsovasilis K. , Georgiopoulos A. The effect of calcium carbonate administration on nitrogen metabolism in patients on hemodialysis. Proc EDTA-ERA 1985; 22: 83–6.

Bunchman T.E. , Ballal S.H. Treatment of inflow pain by pH adjustment of dialysate in peritoneal dialysis. Perit Dial Int 1991; 11: 179–80.